Summary of Study ST004147
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002609. The data can be accessed directly via it's Project DOI: 10.21228/M8DG1T This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST004147 |
| Study Title | Urinary Multi-Omics Signatures of Preterm Premature Rupture of Membranes: Insights into Microbial and Metabolic Biomarkers |
| Study Summary | Preterm premature rupture of membranes (PPROM) is a significant obstetric complication, often associated with infection-related processes. However, the underlying mechanisms remain poorly understood, particularly regarding the interplay between microbial dysbiosis and host metabolism. To address this, urine samples from women with PPROM and healthy controls were analyzed using 16S rRNA gene sequencing and ¹H NMR-based metabolomics. Microbiota analysis revealed increased abundance of Hoylesella, Escherichia, Pseudomonas, and Enterococcus in the PPROM group, whereas Lactobacillus and Limosilactobacillus dominated in controls. Metabolomics identified key metabolites with diagnostic potential. Receiver operating characteristic (ROC) analysis showed that hippurate, formate, citrate, glycolate, serine, valine, and isoleucine had high discriminatory accuracy (AUC > 0.7), while β-glucose, asparagine, pyroglutarate, 2-hydroxyglutarate, tyrosine, creatinine, and imidazole had moderate predictive power. The PPROM group exhibited increased valine, isoleucine, asparagine, and β-glucose, while others decreased compared to controls. Multi-omics integration revealed robust correlations between specific bacterial species and urinary metabolites, suggesting interactions between microbial dysbiosis and host metabolic pathways. These findings demonstrate distinct microbial and metabolic signatures in the urine of women with PPROM and support the utility of urinary multi-omics analysis in advancing understanding of PPROM pathophysiology. |
| Institute | Inonu University Department of Biomedical Eng. |
| Last Name | Dogan |
| First Name | Berat |
| Address | Universite Mah. Muhendislik Fakultesi F-Blok No:1-1, Battalgazi, Malatya, 44280, Turkey |
| berat.dogan@inonu.edu.tr | |
| Phone | +90 422 3774908 |
| Submit Date | 2025-08-19 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | fid |
| Analysis Type Detail | NMR |
| Release Date | 2025-10-08 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR002609 |
| Project DOI: | doi: 10.21228/M8DG1T |
| Project Title: | Urinary Multi-Omics Signatures of Preterm Premature Rupture of Membranes: Insights into Microbial and Metabolic Biomarkers |
| Project Summary: | Preterm premature rupture of membranes (PPROM) is a significant obstetric complication, often associated with infection-related processes. However, the underlying mechanisms remain poorly understood, particularly regarding the interplay between microbial dysbiosis and host metabolism. To address this, urine samples from women with PPROM and healthy controls were analyzed using 16S rRNA gene sequencing and ¹H NMR-based metabolomics. Microbiota analysis revealed increased abundance of Hoylesella, Escherichia, Pseudomonas, and Enterococcus in the PPROM group, whereas Lactobacillus and Limosilactobacillus dominated in controls. Metabolomics identified key metabolites with diagnostic potential. Receiver operating characteristic (ROC) analysis showed that hippurate, formate, citrate, glycolate, serine, valine, and isoleucine had high discriminatory accuracy (AUC > 0.7), while β-glucose, asparagine, pyroglutarate, 2-hydroxyglutarate, tyrosine, creatinine, and imidazole had moderate predictive power. The PPROM group exhibited increased valine, isoleucine, asparagine, and β-glucose, while others decreased compared to controls. Multi-omics integration revealed robust correlations between specific bacterial species and urinary metabolites, suggesting interactions between microbial dysbiosis and host metabolic pathways. These findings demonstrate distinct microbial and metabolic signatures in the urine of women with PPROM and support the utility of urinary multi-omics analysis in advancing understanding of PPROM pathophysiology. |
| Institute: | Inonu University Department of Biomedical Eng. |
| Last Name: | Dogan |
| First Name: | Berat |
| Address: | Universite Mah. Muhendislik Fakultesi F-Blok No:1-1, Battalgazi, Malatya, 44280, Turkey |
| Email: | berat.dogan@inonu.edu.tr |
| Phone: | +90 422 3774908 |
Subject:
| Subject ID: | SU004297 |
| Subject Type: | Human |
| Subject Species: | Homo sapiens |
| Taxonomy ID: | 9606 |
| Gender: | Female |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
| mb_sample_id | local_sample_id | Sample source | Group | Injection order |
|---|---|---|---|---|
| SA480180 | Control_1 | urine | Control | 1 |
| SA480181 | Control_15 | urine | Control | 10 |
| SA480182 | Control_16 | urine | Control | 11 |
| SA480183 | Control_17 | urine | Control | 12 |
| SA480184 | Control_19 | urine | Control | 13 |
| SA480185 | Control_22 | urine | Control | 14 |
| SA480186 | Control_23 | urine | Control | 15 |
| SA480187 | Control_25 | urine | Control | 16 |
| SA480188 | Control_26 | urine | Control | 17 |
| SA480189 | Control_27 | urine | Control | 18 |
| SA480190 | Control_28 | urine | Control | 19 |
| SA480191 | Control_2 | urine | Control | 2 |
| SA480192 | Control_30 | urine | Control | 20 |
| SA480193 | Control_31 | urine | Control | 21 |
| SA480194 | Control_32 | urine | Control | 22 |
| SA480195 | Control_33 | urine | Control | 23 |
| SA480196 | Control_36 | urine | Control | 24 |
| SA480197 | Control_37 | urine | Control | 25 |
| SA480198 | Control_38 | urine | Control | 26 |
| SA480199 | Control_39 | urine | Control | 27 |
| SA480200 | Control_40 | urine | Control | 28 |
| SA480201 | Control_42 | urine | Control | 29 |
| SA480202 | Control_5 | urine | Control | 3 |
| SA480203 | Control_43 | urine | Control | 30 |
| SA480204 | Control_45 | urine | Control | 31 |
| SA480205 | Control_46 | urine | Control | 32 |
| SA480206 | Control_47 | urine | Control | 33 |
| SA480207 | Control_48 | urine | Control | 34 |
| SA480208 | Control_49 | urine | Control | 35 |
| SA480209 | Control_50 | urine | Control | 36 |
| SA480210 | Control_51 | urine | Control | 37 |
| SA480211 | Control_52 | urine | Control | 38 |
| SA480212 | Control_53 | urine | Control | 39 |
| SA480213 | Control_6 | urine | Control | 4 |
| SA480214 | Control_54 | urine | Control | 40 |
| SA480215 | Control_55 | urine | Control | 41 |
| SA480216 | Control_56 | urine | Control | 42 |
| SA480217 | Control_A1 | urine | Control | 43 |
| SA480218 | Control_A2 | urine | Control | 44 |
| SA480219 | Control_A3 | urine | Control | 45 |
| SA480220 | Control_7 | urine | Control | 5 |
| SA480221 | Control_9 | urine | Control | 6 |
| SA480222 | Control_12 | urine | Control | 7 |
| SA480223 | Control_13 | urine | Control | 8 |
| SA480224 | Control_14 | urine | Control | 9 |
| SA480225 | PPROM_2 | urine | PPROM | 46 |
| SA480226 | PPROM_4 | urine | PPROM | 47 |
| SA480227 | PPROM_5 | urine | PPROM | 48 |
| SA480228 | PPROM_6 | urine | PPROM | 49 |
| SA480229 | PPROM_7 | urine | PPROM | 50 |
| SA480230 | PPROM_8 | urine | PPROM | 51 |
| SA480231 | PPROM_9 | urine | PPROM | 52 |
| SA480232 | PPROM_10 | urine | PPROM | 53 |
| SA480233 | PPROM_11 | urine | PPROM | 54 |
| SA480234 | PPROM_12 | urine | PPROM | 55 |
| SA480235 | PPROM_13 | urine | PPROM | 56 |
| SA480236 | PPROM_14 | urine | PPROM | 57 |
| SA480237 | PPROM_16 | urine | PPROM | 58 |
| SA480238 | PPROM_17 | urine | PPROM | 59 |
| SA480239 | PPROM_18 | urine | PPROM | 60 |
| SA480240 | PPROM_19 | urine | PPROM | 61 |
| SA480241 | PPROM_21 | urine | PPROM | 62 |
| SA480242 | PPROM_22 | urine | PPROM | 63 |
| SA480243 | PPROM_24 | urine | PPROM | 64 |
| SA480244 | PPROM_25 | urine | PPROM | 65 |
| SA480245 | PPROM_26 | urine | PPROM | 66 |
| SA480246 | PPROM_27 | urine | PPROM | 67 |
| SA480247 | PPROM_29 | urine | PPROM | 68 |
| SA480248 | PPROM_31 | urine | PPROM | 69 |
| SA480249 | PPROM_32 | urine | PPROM | 70 |
| SA480250 | PPROM_33 | urine | PPROM | 71 |
| SA480251 | PPROM_34 | urine | PPROM | 72 |
| SA480252 | PPROM_35 | urine | PPROM | 73 |
| SA480253 | PPROM_36 | urine | PPROM | 74 |
| SA480254 | PPROM_37 | urine | PPROM | 75 |
| SA480255 | PPROM_38 | urine | PPROM | 76 |
| SA480256 | PPROM_A1 | urine | PPROM | 77 |
| SA480257 | PPROM_A2 | urine | PPROM | 78 |
| Showing results 1 to 78 of 78 |
Collection:
| Collection ID: | CO004290 |
| Collection Summary: | Urine samples were collected from PPROM patients admitted to the Department of Obstetrics and Gynecology at Inönü University Turgut Özal Medical Center and healthy pregnant women without preterm labor as controls. For each participant, samples were collected in two separate tubes for metagenomics and metabolomics analyses and stored at –80°C until processing. Ethical approval was obtained from the Malatya Clinical Research Ethics Committee (2020/91), and all participants provided written informed consent. PPROM diagnosis was confirmed by amniotic fluid leakage observed during a sterile speculum exam or a positive AmniSure test. Exclusion criteria included systemic diseases (e.g., hypertension, diabetes), pregnancy complications (e.g., gestational diabetes, hypertensive disorders), fetal anomalies, prior urogenital surgery, urolithiasis, congenital anomalies, signs of acute fetal distress, or recent antibiotic/probiotic use within one month. Control participants were healthy pregnant women without systemic disease, preterm labor, vaginal bleeding, or recent antibiotic/probiotic exposure. To prevent contamination, urine was collected via sterile catheterization and immediately stored at –80°C. |
| Sample Type: | Urine |
Treatment:
| Treatment ID: | TR004306 |
| Treatment Summary: | Urine samples stored at –80°C were thawed at room temperature before ¹H NMR analysis. Each 400 µL sample was mixed with 200 µL of phosphate buffer (0.2 M Na₂HPO₄ and 0.2 M KH₂PO₄ in D₂O, pH 7.4) for pH stabilization and field-frequency locking. The mixture was centrifuged at 5000 × g for 5 minutes at 5°C, and 550 µL of the supernatant was transferred into 5 mm NMR tubes. |
Sample Preparation:
| Sampleprep ID: | SP004303 |
| Sampleprep Summary: | Analyses were performed using a Bruker Avance III HD 600 MHz spectrometer (Bruker GmBH, Germany) with a 5 mm broadband BBO probehead (¹H/¹³C/¹⁵N) at the Inönü University Scientific and Technological Research Center. Sample and probe temperatures were stabilized at 296 K with a Bruker Cooling Unit (BCU). The ¹D-NOESY-presaturation (noesygppr1d, Bruker) pulse sequence (RD ‒ 180° ‒ {mixing} ‒ 90° ‒ FID) was applied to suppress water and protein-derived signals. The spectra were recorded with a spectral width of 7002.8 Hz, 32 K data points, and a 40 ms mixing time. Additionally, weak presaturation pulses (1.1E-4W power) were applied to enhance water signal suppression. Each analysis was performed with 128 scans (pulses) and a 4 s relaxation delay to improve the signal-to-noise (S/N) ratio. |
Analysis:
| Analysis ID: | AN006876 |
| Analysis Type: | NMR |
| Num Factors: | 78 |
| Num Metabolites: | 53 |
| Results File: | ST004147_AN006876_Results.txt |
| Units: | NMR spectral bin intensities (arbitrary units) #NMR_METABOLITE_DATA NMR_METABOLITE_DATA:UNITS |
NMR:
| NMR ID: | NM000316 |
| Analysis ID: | AN006876 |
| Instrument Name: | Bruker Avance III HD |
| Instrument Type: | FT-NMR |
| NMR Experiment Type: | 1D-1H |
| Spectrometer Frequency: | 600 MHz |